AU5254198A - Method of treating kaposi's sarcoma by vitamin-d3 receptor agonists - Google Patents

Method of treating kaposi's sarcoma by vitamin-d3 receptor agonists

Info

Publication number
AU5254198A
AU5254198A AU52541/98A AU5254198A AU5254198A AU 5254198 A AU5254198 A AU 5254198A AU 52541/98 A AU52541/98 A AU 52541/98A AU 5254198 A AU5254198 A AU 5254198A AU 5254198 A AU5254198 A AU 5254198A
Authority
AU
Australia
Prior art keywords
sarcoma
vitamin
receptor agonists
treating kaposi
kaposi
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU52541/98A
Inventor
Parkash S Gill
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU5254198A publication Critical patent/AU5254198A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2053—IL-8
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1136—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against growth factors, growth regulators, cytokines, lymphokines or hormones
AU52541/98A 1996-11-13 1997-11-12 Method of treating kaposi's sarcoma by vitamin-d3 receptor agonists Abandoned AU5254198A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3078796P 1996-11-13 1996-11-13
US60030787 1996-11-13
PCT/US1997/020613 WO1998020866A2 (en) 1996-11-13 1997-11-12 Method of treating kaposi's sarcoma by vitamin-d3 receptor agonists

Publications (1)

Publication Number Publication Date
AU5254198A true AU5254198A (en) 1998-06-03

Family

ID=21856035

Family Applications (1)

Application Number Title Priority Date Filing Date
AU52541/98A Abandoned AU5254198A (en) 1996-11-13 1997-11-12 Method of treating kaposi's sarcoma by vitamin-d3 receptor agonists

Country Status (2)

Country Link
AU (1) AU5254198A (en)
WO (1) WO1998020866A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2801305B1 (en) 1999-11-24 2002-12-06 Galderma Res & Dev VITAMIN D ANALOGS

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5470824A (en) * 1991-05-31 1995-11-28 The Regents Of The University Of California Method to treat Kaposi's sarcoma
AU5654096A (en) * 1995-05-05 1996-11-21 Imperial College Of Science, Technology And Medicine Antisense peptides

Also Published As

Publication number Publication date
WO1998020866A3 (en) 1998-07-23
WO1998020866A2 (en) 1998-05-22

Similar Documents

Publication Publication Date Title
AU5789396A (en) Apparatus for skin resurfacing
AU6029696A (en) Adjustable sizing apparatus for heart annulus
GB2319250B (en) Derivatives of 6,8-Difluoro-7-Hydroxycoumarin
PL334218A1 (en) Derivatives of 2-(purin-9-yl)-tetrahydrofurane 3,4-diole
AU4838097A (en) Apparatus for the treatment of specimens
AU5487696A (en) Apparatus for cardiac ablation
AU1128297A (en) Composition for treating pain
PL324992A1 (en) Novel derivatives of 2,3-dioxotetrahydoquinoxaline
PL329121A1 (en) Substituted derivatives of 1,2,3,4-tetrahydronaphtalene
AU4329396A (en) Use of 3,4-diphenylchromans
PL327733A1 (en) Method of obtaining polyethylene (2,6-naphtalate)
HUP9901176A3 (en) Process for the preparation of 2,2'-bipyrrolyl-pyrromethene (prodigiosins) derivatives and their intermediates
HUP9602332A2 (en) Method of preparing 4,6-dichloro pyrimides
AU1970592A (en) Method to treat kaposi's sarcoma
AU3672597A (en) Novel genes of kaposi's sarcoma associated herpesvirus
AU6714996A (en) 2-(fluorenonyl)-carbapenems, compositions and methods of use
PL322279A1 (en) Method of obtaining 1,2-benzoylthiazolin-3-ones
FR2733227B1 (en) PROCESS FOR THE PREPARATION OF 1,1-DIFLUOROETHANE
IL118200A0 (en) Process for the preparation of substituted 2-fluoro-pyrimidines
AU5254198A (en) Method of treating kaposi's sarcoma by vitamin-d3 receptor agonists
PL327141A1 (en) Method of obtaining 9,11 beta-epoxysteroides
AU4897397A (en) Proteins of kaposi's sarcoma associated herpesvirus
IL118973A (en) Process for the preparation of substituted aminocarbonyltriazolinones
AU7113996A (en) Methods of treating beta-amyloid-associated conditions
AU2874497A (en) Balanites aegyptiaca method of treatment